Abstract Intratumoral heterogeneity in human epidermal growth factor receptor 2 (HER2)-positive breast cancer can lead to variable therapeutic responses, but its spatially resolved molecular characteristics in formalin-fixed, paraffin-embedded (FFPE) tissue are not fully characterized. In this study, we applied spatial multi-omic profiling to investigate how regional differences in HER2 expression within the same HER2-positive breast cancer tissue are reflected at the proteome and transcriptome levels. Using hematoxylin and eosin (H Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1219.
Shin et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: